Skip to main content
Log in

T2DM forecast to cost €21 billion in Germany by 2040

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Waldeyer R, et al. Projection of the burden of Type 2 diabetes mellitus in Germany: a demographic modelling approach to predict the direct medical excess costs from 2010 to 2040. Diabetic Medicine : 18 Mar 2013. Available from: URL: http://dx.doi.org/10.1111/dme.12177

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

T2DM forecast to cost €21 billion in Germany by 2040. PharmacoEcon Outcomes News 676, 9 (2013). https://doi.org/10.1007/s40274-013-0328-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0328-3

Navigation